VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Profit Before Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹72 Cr | ₹45 Cr | ₹38 Cr | ₹36 Cr | ₹49 Cr |
What is the latest Profit Before Tax of VENUS REMEDIES ?
| Year | Profit Before Tax |
|---|---|
| Mar2025 | ₹72 Cr |
| Mar2024 | ₹45 Cr |
| Mar2023 | ₹38 Cr |
| Mar2022 | ₹36 Cr |
| Mar2021 | ₹49 Cr |
How is Profit Before Tax of VENUS REMEDIES Trending?
| Years | Profit Before Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹72 Cr | 60.89 | |
| Mar2024 | ₹45 Cr | 17.70 | |
| Mar2023 | ₹38 Cr | 4.18 | |
| Mar2022 | ₹36 Cr | -25.01 | |
| Mar2021 | ₹49 Cr | - | |
Compare Profit Before Tax of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,023.1 Cr | 0.2% | 70.1% | 128% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,753.0 Cr | -0.2% | 6.1% | 0.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,998.0 Cr | -1.4% | -4.9% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,186.0 Cr | 0.8% | 5% | 12.9% | Stock Analytics | |
| CIPLA | ₹120,960.0 Cr | -1.3% | -0.5% | 1.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,759.0 Cr | -0.7% | 5.1% | 4.9% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 0.2% |
70.1% |
128% |
| SENSEX | -0.6% |
2.2% |
5.3% |
You may also like the below Video Courses